Arkolith/Insider Trading/MYMD/Form 4

Rivard Paul

Chief Legal OfficerMyMD Pharmaceuticals, Inc. (MYMD) · full profile →Form 4 · filed Aug 24, 2023
Net Buying
Open-Market Buys
$167K
Open-Market Sells
$0
Net Open-Market Flow
$167K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 24, 2023Buy(P)150K$1.11$167K400K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-030111) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML